MedTrace Logo

Structured Neuromuscular Exercise Program

NCT07596420 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-05-19

No results posted yet for this study

Summary

This randomized controlled trial aims to investigate the effects of an 8-week structured neuromuscular exercise program on running performance and lower extremity biomechanics in recreational runners. The program includes progressive exercises focusing on hip and core strength, balance, plyometric control, and running-specific mobility. Participants will be randomly assigned to an intervention or control group. The intervention group will perform the neuromuscular training twice a week for eight weeks, while the control group will not receive any structured exercise. Pre- and post-intervention assessments will include biomechanical analysis and functional performance tests. The study aims to provide evidence for the preventive and performance-enhancing benefits of neuromuscular training in runners.

Conditions

  • Running Biomechanics
  • Neuromuscular Control
  • Running-Related Injury Prevention
  • Recreational Runners

Interventions

BEHAVIORAL

Structured Neuromuscular Exercise Program

An 8-week structured neuromuscular exercise program including progressive exercises targeting hip and core strength, dynamic balance, plyometric control, and running-specific mobility. The program is performed twice per week under supervision. It is designed to improve running performance, neuromuscular control, and lower limb biomechanics in recreational runners.

Sponsors & Collaborators

  • Elif Tunç

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07596420 on ClinicalTrials.gov